Form 4: Elanco Animal Health Executive Shiv O'Neill Reports Stock Transactions

Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, reports acquisition and disposal of common stock and grant of stock options.

Summary

• On March 1, 2024, Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, was granted 15,596 shares of common stock.
• On the same day, O'Neill disposed of 1,354 shares of common stock to cover tax liabilities at a price of $16.03 per share.
• Following these transactions, O'Neill beneficially owns 23,773 shares of Elanco Animal Health Inc.
• O'Neill was also granted 34,014 employee stock options with an exercise price of $16.03, vesting in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027, and expiring on March 1, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects standard executive compensation practices. The grant of stock options and restricted stock units is a positive sign, but the disposal of shares for tax purposes is a neutral event.

Positives

• The grant of restricted stock units and stock options to a key executive suggests a long-term incentive and alignment with the company's success.

Negatives

• The disposal of shares to cover tax liabilities, while common, slightly reduces the executive's direct stake in the company.

Future Outlook

The vesting schedule of the restricted stock units and stock options indicates a multi-year commitment by the executive.

Industry Context

Stock transactions by company executives are routinely monitored as indicators of management's confidence in the company's prospects and are a normal part of executive compensation.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment due to the alignment of executive interests with company performance.

Key Dates